Relationship between fentanyl dosage and immune function in the postoperative period
Israel Z Yardeni1, Benzion Beilin, Eduard Mayburd
1Department of Anesthesiology, Rabin Medical Center, Hasharon Hospital, Petah Tiqva, Israel.
Journal of Opioid Management
|May 1, 2008
Summary
This study investigated how different fentanyl doses affect immune responses after surgery. Intermediate and large doses of fentanyl reduced pro-inflammatory cytokines, suggesting more stable immune function compared to small doses.
Area of Science:
- Immunology
- Anesthesiology
- Pharmacology
Background:
- Anesthesia and surgery can impair immune function, leading to excessive inflammation and reduced cell-mediated immunity.
- Opioids, commonly used in anesthesia, can suppress both humoral and cellular immune responses.
Purpose of the Study:
- To examine the effect of various fentanyl doses on perioperative cytokine production.
- To investigate the impact of different fentanyl dosages on immune function post-surgery.
Main Methods:
- Sixty patients were randomly assigned to receive small (SDFA), intermediate (IDFA), or large (LDFA) doses of fentanyl.
- Ex vivo secretion of IL-1beta, IL-2, IL-6, IL-10, and NK cell cytotoxicity (NKCC) from peripheral blood mononuclear cells (PBMC) was measured pre- and post-surgery.
Main Results:
- Fentanyl dosage significantly altered postoperative secretion patterns of IL-1beta, IL-6, and IL-10.
- IL-1beta, IL-6, and IL-10 secretion patterns differed between SDFA and IDFA/LDFA groups, but were similar between IDFA and LDFA groups.
- Suppression of NKCC and IL-2 secretion was consistent across all three fentanyl dose groups.
Conclusions:
- Intermediate and large fentanyl doses diminished the proinflammatory cytokine response compared to small doses.
- While intermediate and large doses offer more stable immune function, intermediate doses are recommended to mitigate potential side effects associated with large doses.
Related Concept Videos
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...